Invisible Enemy in Kazakhstan
Nazi Legacy Unearthed in Remote Kazakhstan
Free with Audible trial. Cancel anytime.
Quick Facts
| Author | Peter Cave |
| Narrator | Colin Mace |
| Runtime | 7h28m |
| Published | March 24, 2016 |
| Rating | 2.0 / 5 (8,101 ratings) |
| Categories | Literature & Fiction, Action & Adventure, Mystery, Thriller & Suspense, Thriller & Suspense, War & Military, Genre Fiction, Crime Thrillers, Spies & Politics, Espionage |
| Format | Audiobook (Digital) |
| Platform | Audible |
About This Audiobook
In 'Invisible Enemy in Kazakhstan,' Peter Cave weaves a taut, suspenseful narrative that takes listeners on a pulse-pounding journey through the icy, mountainous heart of Kazakhstan. The story centers around a top-secret Nazi research facility buried under Soviet soil, which emerges with chilling clarity as an audacious and harrowing mission for the SAS. Narrated by Colin Mace in a robust and engaging voice, this audiobook delivers a unique blend of mystery, action, and historical intrigue, making it an exhilarating listen. With its vivid setting descriptions and complex characters, 'Invisible Enemy' immerses you in a world where the past shadows the present, and every step could be your last.
Why Listen to Invisible Enemy in Kazakhstan?
- Expert narration by Colin Mace brings every character and scene to life across 7h28m of immersive audio.
- Highly rated at 2.0 stars by 8,101 listeners.
- Free with your Audible trial — keep the audiobook forever even if you cancel.
- Perfect for commutes, workouts, and relaxation. Listen anywhere, anytime.
Editor's Review
AudioBook Atlas
Download: Invisible Enemy in Kazakhstan
Some links on this page are affiliate links. If you make a purchase through one of them, we may earn a small commission at no extra cost to you.
Invisible Enemy in Kazakhstan by Peter Cave is an immersive listening experience. Performed by Colin Mace with a runtime of 7h28m, you can start with a free trial that you can cancel at any time. The audiobook remains yours forever, even if you end the trial.